Mebendazole (BullFrog AI)

N/A

Report date: 2024/04/09 16:23:12

Base Information

Drug NameMebendazole (BullFrog AI)
Drug Alias NameBF-222
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionMicrotubule-associated proteins inhibitors
TargetsMicrotubule-associated proteins
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaN/A
Originator CompaniesJohns Hopkins University
China Registration ClassN/A

Develop Information

Active CompaniesBullFrog AI Holdings Inc
Inactive CompaniesN/A
Active IndicationsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A